P3.02c-033 Patterns of Progression and Management of Acquired Resistance to?Anti-PD-1 Antibodies in Advanced Non-Small Cell Lung Cancer

Antony Mersiades; Megan Crumbaker; Bo Gao; Adnan Nagrial; Rina Hui

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >P3.02c-033 Patterns of Progression and Management of Acquired Resistance to?Anti-PD-1 Antibodies in Advanced Non-Small Cell Lung Cancer

【24h】

P3.02c-033 Patterns of Progression and Management of Acquired Resistance to?Anti-PD-1 Antibodies in Advanced Non-Small Cell Lung Cancer

机译：P3.02C-033抗PD-1抗体在先进的非小细胞肺癌中的抗PD-1抗体的进展和管理模式

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 》 |2017年第1期| 共1页
作者
Antony Mersiades; Megan Crumbaker; Bo Gao; Adnan Nagrial; Rina Hui;
展开▼
作者单位

Medical Oncology Crown Princess Mary Cancer Care Centre Westmead Hospital;

Medical Oncology Crown Princess Mary Cancer Care Centre Westmead Hospital;

Medical Oncology Blacktown Cancer and Haematology Centre;

Medical Oncology Crown Princess Mary Cancer Care Centre Westmead Hospital;

Medical Oncology Crown Princess Mary Cancer Care Centre Westmead Hospital;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. P3.02c-033 Patterns of Progression and Management of Acquired Resistance to?Anti-PD-1 Antibodies in Advanced Non-Small Cell Lung Cancer [J] . Antony Mersiades, Megan Crumbaker, Bo Gao, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017 ,第1期

机译：P3.02C-033抗PD-1抗体在先进的非小细胞肺癌中的抗PD-1抗体的进展和管理模式
2. Relationship between Overall Survival and Response or Progression-Free Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with Anti-PD-1/PD-L1 Antibodies [J] . Shukuya Takehito, Mori Keita, Amann Joseph M., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2016 ,第11期

机译：通过抗PD-1 / Pd-L1抗体治疗的先进非小细胞肺癌患者的整体存活与反应或无进展生存的关系
3. Retreatment With Anti-PD-L1 Antibody in Advanced Non-small Cell Lung Cancer Previously Treated With Anti-PD-1 Antibodies [J] . Fujita Kohei, Uchida Naohiro, Yamamoto Yuki, Anticancer Research: International Journal of Cancer Research and Treatment . 2019 ,第7期

机译：用先前用抗PD-1抗体处理的先进的非小细胞肺癌中的抗PD-L1抗体的再处理
4. Effects of Erlotinib after Acquired Resistance to Gefitinib in Advanced Non-small-cell Lung Cancer [C] . Pan Jingjing, Shi Meiqi, Feng Jifeng Biomedical Engineering and Biotechnology (iCBEB), 2012 International Conference on . 2012

机译：吉非替尼耐药对晚期非小细胞肺癌患者的厄洛替尼治疗效果
5. Evaluation of Symptom Management in Patients with Advanced Stage (IIIB and IV) Non-Small Cell Lung Cancer [D] . Mann, LaTonya E. 2018

机译：晚期（IIIB和IV）非小细胞肺癌患者症状管理的评估
6. Progression Patterns Treatment and Prognosis Beyond Resistance of Responders to Immunotherapy in Advanced Non-Small Cell Lung Cancer [O] . Yanjun Xu, Hui Li, Yun Fan 2021

机译：除了高小细胞肺癌中患者的抗患者抗性的进展模式治疗和预后
7. P3.02c-033 Patterns of Progression and Management of Acquired Resistance to Anti-PD-1 Antibodies in Advanced Non-Small Cell Lung Cancer [O] . Antony Mersiades, Megan Crumbaker, Bo Gao, 2017

机译：P3.02C-033预期非小细胞肺癌中获得抗PD-1抗体的抗PD-1抗体的进展和管理模式

P3.02c-033 Patterns of Progression and Management of Acquired Resistance to?Anti-PD-1 Antibodies in Advanced Non-Small Cell Lung Cancer

著录项

相似文献

相关主题

期刊订阅